Современные технологии лучевой терапии: IMRT, VMAT с использованием симультантного интегрированного буста (SIB) в комплексномлечении плоскоклеточного рака анального канала
- Авторы: Ткачев С.И.1, Глебовская В.В.1, Расулов А.О.1, Царюк В.Ф.1, Алиев В.А.1, Водяник В.В.1
-
Учреждения:
- ФГБУ Российский онкологический научный центр им. Н.Н.Блохина РАМН, Москва
- Выпуск: Том 16, № 2 (2014)
- Страницы: 60-65
- Раздел: Статьи
- URL: https://journals.rcsi.science/1815-1434/article/view/26963
- ID: 26963
Цитировать
Полный текст
Аннотация
Полный текст
Открыть статью на сайте журналаОб авторах
Сергей Иванович Ткачев
ФГБУ Российский онкологический научный центр им. Н.Н.Блохина РАМН, Москвад-р мед. наук, проф., зав. отд. радиационной онкологии
Валерия Владимировна Глебовская
ФГБУ Российский онкологический научный центр им. Н.Н.Блохина РАМН, Москваканд. мед. наук, науч. сотр. радиологического отд-ния НИИ клинической онкологии
Арсен Османович Расулов
ФГБУ Российский онкологический научный центр им. Н.Н.Блохина РАМН, Москвад-р мед. наук, зав. хирургическим отд-нием №3 (проктологическим) НИИ клинической онкологии
Владимир Федорович Царюк
ФГБУ Российский онкологический научный центр им. Н.Н.Блохина РАМН, Москвад-р мед. наук, вед. науч. сотр. отд-ния хирургического №3 (проктологического) НИИ клинической онкологии
Вячеслав Афандиевич Алиев
ФГБУ Российский онкологический научный центр им. Н.Н.Блохина РАМН, Москваканд. мед. наук, ст. науч. сотр. отд-ния хирургического №3 (проктологического) НИИ клинической онкологии
Виктория Викторовна Водяник
ФГБУ Российский онкологический научный центр им. Н.Н.Блохина РАМН, Москвавед. инженер отд-ния лучевой топометрии и клинической дозиметрии НИИ клинической онкологии
Список литературы
- Mitchell M.P, Abboud M, Eng C et al. Intensity - modulated radiation therapy with concurrent chemotherapy for anal cancer: outcomes and toxicity. Departments of Radiation Oncology Gastrointestinal Medical Oncology Radiation Physics. UT MD Anderson Cancer Center. Houston, TX. Am J Clin Oncol 2013.
- Chuong M.D, Freilich J.M, Hoffe S.E et al. Intensity - modulated radiation therapy vs. 3D conformal radiation therapy for squamous cell carcinoma of the anal canal. Department of Radiation Oncology. Gastrointest Cancer Res 2013; 6 (2): 39-45.
- Saarilahti K, Arponen P, Vaalavirta L et al. The effect of intensity - modulated radiotherapy and high dose rate brachytherapy on acute and late radiotherapy - related adverse events following chemoradiotherapy of anal cancer. Radiother Oncol 2008; 87: 383-90.
- Dubois J, Vieillot S, Moscardo C.L et al. A planning study to compare plans using volumetric modulated arc therapy or intensity - modulated radiation therapy for the treatment of anal cancer. Crlc Val D’aurelle, Montpellier, France. J Radiat Oncol Biol Physics 2009; 75 (3).
- Cox J.D, Stetz J, Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341-6.
- UKCCCR Anal Cancer Working Party. Epidermoid Anal Cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil and Mitomycin. Lancet 1996; 348: 1049-54.
- Bilimoria K.Y, Bentrem D.J, Rock C.E et al. Outcomes and prognostic factors for squamous - cell carcinoma of the anal canal. Analysis of patients from the National Cancer Data Base. Dis Colon Rectum 2009; 52: 624-31.
- Engstrom P.F, Amoletti J.P, Benson A.B et al. NCCN Practice Guidelines: Anal Cancer. Vers. 2.2009; www.nccn.org/professionals/physician
- Glynne-Jones R, Northover J, Cervantes A. ESMO Guidelines Working Group. Anal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow - up. Ann Oncol 2010; 21 (Suppl. 5): v87-92.
- Nigro N.D, Seydel H.G, Considine B. Jr et al. Combined radiotherapy and chemotherapy for squamous cell carcinoma of the anal canal. Cancer 1983; 51: 1826-9.
- Leichman L, Nigro N, Vaitkevicius V.K et al. Cancer of the anal canal: Model for preoperative adjuvant combined modality therapy. Am J Med 1985; 78: 211-5.
- Bartelink H, Roelofsen F, Eschwege F et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a Phase III randomized trial of the European Organization for Research and Treatment of Cancer radiotherapy and gastrointestinal cooperative groups. J Clin Oncol 1997; 15: 2040-9.
- Flam M, John M, Pajak T.F et al. Role of mitomycin in combination with fluorouracil and radiotherapy and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized Intergroup Study. J Clin Oncol 1996; 14: 2527-39.
- Martenson J.A, Lipsitz S.R, Leftkopoulou M et al. Results of combined modality therapy for patients with anal cancer (E-7283): An Eastern Cooperative Oncology Group study. Cancer 1995; 76: 1731-6.
- Borzomati D, Valeri S, Ripetti V et al. Persisting anal ulcer after radiotherapy for anal cancer: recurrence of disease or late radiation - related complication? Hepatogastroenterol 2005; 52: 780-4.
- Tanum G, Tveit K.M, Karlsen K.O. Chemoradiotherapy of anal carcinoma: Tumour response and acute toxicity. Oncology 1993; 50: 14-7.
- Schwarz J.K, Siegel B.A, Dehdashti F et al. Tumor response and survival predicted by post - therapy FDG-PET/CT in anal cancer. Int J Radiat Oncol Biol Phys 2008; 71: 180-6.
- Ajani J.A, Winter K.A, Gunderson L.L et al. Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: The intergroup trial (RTOG 98-11). Cancer 2010.
- Ajani J.A, Winter K.A, Gunderson L.L et al. US Intergroup Anal Carcinoma Trial: Tumor diameter predicts for colostomy. J Clin Oncol 2009; 27: 1116-21.
- James R, Wan S, Glynne-Jones R et al. A randomised trial of chemoradiation using Mitomycin or cisplatin, with or without maintenance cisplatin/5FU in squamous cell carcinoma of the anus. J Clin Oncol 2009; 2 (2) 27: 18S; 797s. Abstr. LBA-4009.
- Ajani J.A, Winter K.A, Gunderson L.L et al. Fluorouracil, mitomycin and radiotherapy vs. fluorouracil, cisplatin and radiotherapy for carcinoma of the anal canal: A randomized controlled trial. JAMA 2008; 199: 1914-21.
- Cummings B.J, Brierley J.D. Anal canal. In: C.Perez, L.Brady, E.Halperin et al. (ed.). Principles and Practice of Radiation Oncology. 4th ed. Lippincott Williams & Wilkins: Philadelphia 2004; p. 1630-48.
- Matthews J. Early anal canal carcinoma - the Trans-Tasman Radiation Oncology Group (TROG) experience in TROG 99.02 study. Austral Radiol 2005; 49: A3.
- Salama J.K, Mell L.K, Schomas D.A et al. Concurrent chemotherapy and intensity - modulated radiation therapy for anal canal cancer patients: A multicenter experience. J Clin Oncol 2007; 25: 4581-6.
- Myerson R.J, Garofalo M.C, El Naqa I et al. Elective clinical target volumes for conformal therapy in anorectal cancer: A radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 2009; 74: 824-30.
- Kachnic L, Winter K, Myerson R et al. RTOG 0529: A phase II evaluation of dose painted IMRT in combination with 5-fluorouracil and Mitomycin C for reduction of acute morbidity in carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 2009; 75 (3). Suppl. Proc ASTRO S5. Abstr. 10.